Literature DB >> 26411560

Hematological Indices at Birth of Infants of HIV-Positive Mothers Participating in a Prevention of Mother-to-Child Transmission Program.

Ijeoma Obumneme-Anyim1, Ngozi Ibeziako2, Ifeoma Emodi3, Anthony Ikefuna3, Tagbo Oguonu3.   

Abstract

BACKGROUND: The mother-to-child transmission of HIV, which accounts for 90% of infections in children, has been reduced markedly through the use of antiretroviral drugs by pregnant women and their newborns. Changes to the World Health Organization guidelines support further extension of the prevention of mother-to-child transmission programs with increased risk of toxicity on the fetuses. AIM: To determine the hematological indices at birth of infants exposed in utero to maternal antiretroviral drugs.
METHOD: A comparative analytical study of 126 neonates whose blood samples were analyzed to determine their hematological indices. RESULT: The hemoglobin, hematocrit, the total white blood cell (WBC) count and absolute neutrophil count (ANC) were significantly lower in infants of HIV-positive mothers. The total WBC and ANC were also significantly lower in the highly active antiretroviral therapy. HAART group and those exposed to maternal drugs for <1 year.
CONCLUSION: There are significant changes in the hematological indices of infants of HIV-positive mothers at birth.
© The Author [2015]. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  HIV-infected mothers; birth; hematological indices; infants

Mesh:

Substances:

Year:  2015        PMID: 26411560      PMCID: PMC4892384          DOI: 10.1093/tropej/fmv061

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  29 in total

1.  Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers.

Authors:  Madeleine J Bunders; Vincent Bekker; Henriette J Scherpbier; Kees Boer; Mieke Godfried; Taco W Kuijpers
Journal:  Acta Paediatr       Date:  2005-11       Impact factor: 2.299

2.  Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth.

Authors:  Taha E Taha; Newton Kumwenda; George Kafulafula; Johnstone Kumwenda; Rohit Chitale; Chiwawa Nkhoma; Pauline Katundu; Joshua Mukiibi; Shu Chen; Donald Hoover; Robin Broadhead
Journal:  Ann Trop Paediatr       Date:  2004-12

3.  A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.

Authors:  R E McKinney; M A Maha; E M Connor; J Feinberg; G B Scott; M Wulfsohn; K McIntosh; W Borkowsky; J F Modlin; P Weintrub
Journal:  N Engl J Med       Date:  1991-04-11       Impact factor: 91.245

4.  Mitochondrial toxicity of nucleoside analogues in primary human lymphocytes.

Authors:  Bernhard Setzer; Michael Schlesier; Anna K Thomas; Ulrich A Walker
Journal:  Antivir Ther       Date:  2005

5.  Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants.

Authors:  Cornelia Feiterna-Sperling; Katharina Weizsaecker; Christoph Bührer; Simone Casteleyn; Andrea Loui; Thomas Schmitz; Volker Wahn; Michael Obladen
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

6.  Zidovudine induced pure red cell aplasia: a case report.

Authors:  A Hassan; A A Babadoko; A I Mamman; S A Ahmed
Journal:  Niger J Med       Date:  2009 Jul-Sep

7.  3'-Azido-3'-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells.

Authors:  N Dainiak; M Worthington; M A Riordan; S Kreczko; L Goldman
Journal:  Br J Haematol       Date:  1988-07       Impact factor: 6.998

8.  Zidovudine (AZT) treatment suppresses granulocyte-monocyte colony stimulating factor receptor type alpha (GM-CSFR alpha) gene expression in murine bone marrow cells.

Authors:  Shilpa Chitnis; Debasis Mondal; Krishna C Agrawal
Journal:  Life Sci       Date:  2002-07-12       Impact factor: 5.037

9.  Development of thrombocytosis in HIV+ drug users: impact of antiretroviral therapy.

Authors:  M J Miguez-Burbano; X Burbano; A Rodriguez; R Lecusay; N Rodriguez; G Shor-Posner
Journal:  Platelets       Date:  2002-05       Impact factor: 3.862

10.  Effect of Maternal HIV-1 Status and Antiretroviral Drugs on Haematological Profiles of South African Infants in Early Life.

Authors:  Diana B Schramm; Fiona Anthony; Busani Mathebula; Gayle Sherman; Ashraf Coovadia; Glenda E Gray; Louise Kuhn; Caroline T Tiemessen
Journal:  Open AIDS J       Date:  2010-08-12
View more
  2 in total

1.  Phagocytosis of a Model Human Immunodeficiency Virus Target by Human Breast Milk Leukocytes Is Predominantly Granulocyte-Driven When Elicited by Specific Antibody.

Authors:  Rebecca L R Powell; Alisa Fox; Xiaomei Liu; Vincenza Itri
Journal:  Breastfeed Med       Date:  2019-03-13       Impact factor: 1.817

2.  Adverse effects in children exposed to maternal HIV and antiretroviral therapy during pregnancy in Brazil: a cohort study.

Authors:  Adriane M Delicio; Giuliane J Lajos; Eliana Amaral; Fernanda Cavichiolli; Marina Polydoro; Helaine Milanez
Journal:  Reprod Health       Date:  2018-05-10       Impact factor: 3.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.